The National Brain Tumor Society, a nonprofit dedicated to the brain tumor community in the United States, recently announced a new partnership with the Brain Science Foundation. Under the terms of the partnership, the organizations have established the Meningioma Research Fund to raise and grant funds specifically for meningioma research to identify and advance treatments aimed at improving survival and quality of life.
Steven Haley
David Arons
“Given the legacy of the Brain Science Foundation, its association with meningioma, and our shared goals with the National Brain Tumor Society to fund research aimed to advance the development of treatments, it quickly became evident that the community of patients, advocates, and health-care providers could benefit from a formal collaboration between our respective organizations,” said Steven Haley, Founder of the Brain Science Foundation.
David Arons, Chief Executive Officer of the National Brain Tumor Society, said, “Medical research directed toward meningioma is disproportionately small compared to other brain tumor types.… This partnership with the Brain Science Foundation and the creation of the Meningioma Research Fund will allow us to invest in science and accelerate research that is aimed at advancing better treatment options for these patients.” ■
